Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia.
BACKGROUND:Treatment of patients with chronic myeloid leukaemia (CML) has become increasingly difficult in recent years due to the variety of treatment options available and challenge deciding on the most appropriate treatment strategy for an individual patient. To facilitate the treatment strategy...
Main Authors: | Haneen Banjar, Damith Ranasinghe, Fred Brown, David Adelson, Trent Kroger, Tamara Leclercq, Deborah White, Timothy Hughes, Naeem Chaudhri |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5207707?pdf=render |
Similar Items
-
Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System
by: Haneen Banjar, et al.
Published: (2017-01-01) -
Corrigendum to “Intelligent Techniques Using Molecular Data Analysis in Leukaemia: An Opportunity for Personalized Medicine Support System”
by: Haneen Banjar, et al.
Published: (2018-01-01) -
Predictors of imatinib response in patients with chronic myeloid leukaemia
by: Crossman, Lucy C.
Published: (2006) -
Molecular mechanisms of imatinib resistance in chronic myeloid leukaemia
by: Wang, Lihui
Published: (2011) -
Bisphosphonates in the treatment of Imatinib-resistant chronic myeloid leukaemia
by: Chuah, Charles Thuan Heng
Published: (2006)